Regent Pacific Group Limited (HKG:0575)
0.9500
+0.0300 (3.26%)
Aug 1, 2025, 3:43 PM HKT
Bally's Revenue
In the year 2024, Regent Pacific Group had annual revenue of $719.00K USD with 147.08% growth. Regent Pacific Group had revenue of $676.00K in the half year ending December 31, 2024, with 569.31% growth.
Revenue
$719.00K
Revenue Growth
+147.08%
P/S Ratio
49.64
Revenue / Employee
$42.29K
Employees
17
Market Cap
277.22M
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 719.00K | 428.00K | 147.08% |
Dec 31, 2023 | 291.00K | 177.00K | 155.26% |
Dec 31, 2022 | 114.00K | -3.14M | -96.50% |
Dec 31, 2021 | 3.25M | 1.58M | 94.85% |
Dec 31, 2020 | 1.67M | 1.51M | 918.29% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 32.49B |
Hansoh Pharmaceutical Group Company | 13.05B |
Innovent Biologics | 10.03B |
JD Health International | 61.89B |
Akeso | 2.26B |
WuXi Biologics | 19.87B |
Sino Biopharmaceutical | 30.72B |
CSPC Pharmaceutical Group | 28.99B |